ARIVINE
LIVE

Serial Number

79101583

Owner

MedDrop Technology AG

Attorney

Aimee L. Kaplan

Filing Date

May 11, 2011

Add to watchlist:

No watchlists yet
View on USPTO

ARIVINE Trademark

Serial Number: 79101583 • Registration: 4243987

ARIVINE is a trademark filed by MedDrop Technology AG on May 11, 2011. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MedDrop Technology AG (8 trademarks)

Witellikerweg 10

Entity Type: 25

Trademark Details

Filing Date

May 11, 2011

Registration Date

November 20, 2012

Published for Opposition

September 4, 2012

Cancellation Date

May 12, 2021

Goods & Services

[ Medical anti-itching agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions; anti-allergic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions; medical wound healing agents, namely, medicated lotions, fluids, gels, sprays, creams, emulsions, microemulsions; medical agents for treating hematoma, namely, medicated lotions, fluids, gels, sprays, creams, emulsions, microemulsions; hygienic preparations for medical purposes, namely, hygienic lotions, fluids, gels, sprays, emulsions, microemulsions, pads, tissues, bandages, antibacterial hand lotions; antimycotic agents, namely, medicated capsules, tablets, and dragees; medicated antimycotic lotions, fluids, gels, sprays, creams, emulsions, and microemulsions, all for medical purposes; antibacterial agents, namely, capsules, tablets, dragees, antibacterial lotions, fluids, gels, sprays, creams, emulsions, microemulsions, all for medical purposes as far as comprised by International Class 5; antiviral agents, namely, capsules, tablets, dragees, antiviral lotions, fluids, gels, sprays, creams, emulsions, microemulsions for medical purposes; medical anticoagulation agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions; medical anesthetic agents for surgical use, namely, capsules, tablets, dragees, injection fluids, lotions, gels, sprays, creams, emulsions, microemulsions; medical skin and body treating agents in the nature of lotions, fluids, gels, sprays, creams, sprays, fluids, emulsions, microemulsions for skin care and beauty; medical analgesic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions, injection fluids; pharmaceutical and veterinary preparations in the form of fluids, emulsions, microemulsion, creams for treating pain, inflammation, infection, trauma; medical preparations in the form of microemulsions for treating pain, inflammation, infection, trauma, wounds, injuries, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma; veterinary preparations in the form of microemulsions for treating pain, inflammation, infection, trauma, wounds, injuries, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma for mammals such as horses, dogs, pigs, cats; intra and transcutaneous pharmaceutical-medical injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts for treating pain, inflammation, infection, trauma, wounds, injuries, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma; anti-inflammatory injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts, analgesic anesthetic surgical or non surgical injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts; injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts for treating neuralgia, eczema, neurodermatitis, and diabetic disease; injection syringes for medical purposes; topically sub, intra and transdermally applicable pharmaceutical medical skin and mucosa preparations, namely, lotions, fluids, gels, sprays, creams, emulsions, and microemulsions, all for medical skin and body care treatment; medical-pharmaceutical preparations, namely, topical agents such as, gels, emulsions, microemulsions for treating sports injuries, pain, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma; ] surgical implants comprising living tissue

[ Cosmetic agents, namely, lotions, creams, emulsions, and microemulsions for body, hair and skin beauty caring; cosmetic agents, namely, fluids, gels, and sprays for the body and the skin; body, hair and skin cleansing cosmetic agents, namely, cleansing lotions, fluids, gels, sprays, emulsions, microemulsions in the nature of body, hand, eye, skin, facial lotions, body, hand, skin, and facial creams, shower gels, body and skin beauty creams, soaps; non-medicated cosmetic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions, all for regenerating connective tissue; non-medicated cosmetic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, and microemulsions, all for leg caring; non-medicated cosmetic vein caring agents, namely, lotions, fluids, gels, sprays, creams, emulsions, and micro-emulsions; non-medicated cosmetic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, micro-emulsions, all for covering hematoma ]

Surgical instruments and apparatus; medical and dental instruments and apparatus, namely, medical fluid injectors, and insulin injectors sold empty, drainage tubes, cannulae, surgical clips, scissors, needles, dispensers for applying medicines, medical, dental and/or veterinary testing apparatus, namely, blood testing apparatus for medical purposes, all for use in surgery, and in treating injuries, trauma, infections, fractures, and lesions; veterinary instruments and apparatus, namely, medical fluid injectors, and insulin injectors sold empty, drainage tubes, cannulae, surgical clips, scissors, needles, dispensers for applying medicines, medical, dental and/or veterinary testing apparatus, namely, blood testing apparatus for medical purposes, all for use in surgery, and in treating injuries, trauma, infections, fractures, and lesions; medical atomizing apparatus for atomizing fluids, emulsions, and micro-emulsions; vaporizer for medical purposes, namely, electric vaporizers for upper respiratory conditions

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 28, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 28, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jun 5, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 14, 2020 INTS
INVALIDATION PROCESSED
May 14, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 21, 2020 INTR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 28, 2019 ERRR
CANCELLED SECTION 71
Jun 21, 2019 C71T
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 23, 2014 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 19, 2013 INPR
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 19, 2013 COC.
ASSIGNED TO PARALEGAL
Apr 19, 2013 PLGL
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 19, 2013 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Apr 6, 2013 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 25, 2013 FICS
FINAL DISPOSITION PROCESSED
Feb 25, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 20, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 20, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Oct 15, 2012 GPNX
PUBLISHED FOR OPPOSITION
Sep 4, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 15, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 15, 2012 OP2R
NOTICE OF PUBLICATION
Aug 15, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 27, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 26, 2012 ERFR
FINAL REFUSAL MAILED
Apr 11, 2012 CNFR
FINAL REFUSAL WRITTEN
Apr 10, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2012 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 23, 2012 CHAN
ASSIGNED TO LIE
Mar 5, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2012 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2011 REAP
REFUSAL PROCESSED BY IB
Oct 9, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2011 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2011 RFCR
NON-FINAL ACTION WRITTEN
Sep 15, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 13, 2011 MAFR
ASSIGNED TO EXAMINER
Sep 9, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 8, 2011 REPR